Xingqiao Wen

1.4k citations
41 papers · 1.0k indexed · h-index 16
Topics
Prostate Cancer Treatment and Research (8 papers)Cancer, Lipids, and Metabolism (7 papers)Pediatric Urology and Nephrology Studies (6 papers)

In The Last Decade

Xingqiao Wen

39 papers receiving 1.0k citations

Peers

Xingqiao Wen
Comparison fields: 5 of 92
  • Molecular Biology 449
  • Pulmonary and Respiratory Medicine 295
  • Cancer Research 271
  • Surgery 216
  • Pathology and Forensic Medicine 200
Replace Muxing Kang with:
Muxing Kang China
Jing Ni China
Raffaele Ardito Italy
Cuiling Qi China
Gang Kuang China
Hao Zheng China
Beatrice Faraglia Italy
Yuan Sheng China
Yukihiko Matsuda Japan
Xingqiao Wen relative to Muxing Kang China Muxing Kang's profile →
Citations per field
00.5×2.9×
Muxing Kang · 1×
Citations per year

Countries citing papers authored by Xingqiao Wen

Since Specialization
Citations

This map shows the geographic impact of Xingqiao Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingqiao Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingqiao Wen more than expected).

Fields of papers citing papers by Xingqiao Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingqiao Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingqiao Wen. The network helps show where Xingqiao Wen may publish in the future.

Co-authorship network of co-authors of Xingqiao Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Xingqiao Wen. A scholar is included among the top collaborators of Xingqiao Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingqiao Wen. Xingqiao Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 8
3 8
4 2
5 17
6 15
7 3
8 4
9 9
10 23
11 5
12 1
13 40
14 125
15 1
16 171
17 64
18 19
19 40
20
Effects of dendritic cells co-cultured with CIK cells on renal carcinoma cells
2

About Xingqiao Wen

Xingqiao Wen is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology, having authored 41 papers that have together received 1.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (8 papers), Cancer, Lipids, and Metabolism (7 papers) and Pediatric Urology and Nephrology Studies (6 papers). The work is most often cited by research in Cancer Research (271 citations), Pathology and Forensic Medicine (200 citations) and Pulmonary and Respiratory Medicine (295 citations). Xingqiao Wen has collaborated with scholars based in China, United States and Portugal. Frequent co-authors include Xin Gao, Xiaojuan Li, Hengjun Xiao, Zheng Chen, Jun Chen, Jun Wang, Fátima Carneiro, Weixin Yan, Shuyuan Yeh and Defeng Xu. Their work appears in journals such as Advanced Functional Materials, Cancer Research and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026